Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rheumatol Int ; 42(6): 1105-1112, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-33709178

RESUMEN

Calcium pyrophosphate deposition (CPPD) can be induced by a persistent hypomagnesemia. Tacrolimus is an immunosuppressive treatment especially used in organ transplant, potentially inducer of hypomagnesemia by renal loss. A 53-year-old man, liver transplant 10 months earlier, developed an acute peripheral oligoarthritis of wrist, hip and elbow with fever, associated with acute low back pain. Synovial fluid was sterile, and revealed calcium pyrophosphate crystals. Spinal imaging showed inflammatory changes. Magnesium blood level was low at 0.51 mmol/l, with high fractional excretion in favor of renal loss. Tacrolimus was changed for everolimus, proton pump inhibitor was stopped, and magnesium oral supplementation was started. After 8 months follow-up and slow prednisone tapering, he did not relapse pain. Persistent hypomagnesemia is a rare secondary cause of CPPD. In this entity, drug liability should be investigated such as tacrolimus in organ transplant patient.


Asunto(s)
Calcinosis , Condrocalcinosis , Trasplante de Hígado , Pirofosfato de Calcio/análisis , Condrocalcinosis/inducido químicamente , Condrocalcinosis/diagnóstico , Humanos , Trasplante de Hígado/efectos adversos , Magnesio/análisis , Magnesio/farmacología , Masculino , Persona de Mediana Edad , Líquido Sinovial/química , Tacrolimus/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA